Found 4 matching trials
Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573
PHASE1The main objective of this study is to determine the maximum tolerated dose...
Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
PHASE2This is a Phase 2 open-label, multicenter, single-arm study evaluating the ...
Location
Seoul National University Bundang Hospital
Expansion Study to Evaluate the Efficacy and Safety of HM95573 in BRAF, KRAS or NRAS Mutant Solid Cancers
PHASE1This study evaluates the anti-tumor efficacy and safety of single agent HM9...
Location
Korea, Republic of, Gyeonggi-do
HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
PHASE1This study evaluates the safety, tolerability and pharmacokinetics of HM955...
Location
National Cancer Center